HIGHLIGHTS
- who: S. Ng, mbbs and M. Carrier, md msc from the (UNIVERSITY) have published the Article: SPECIAL ARTICLE, in the Journal: (JOURNAL)
- what: Given their convenience, efficacy, and safety in most patients, doacs are increasingly being used for the prevention and treatment of cancer-associated vte.
SUMMARY
Cancer-associated thrombosis is a major cause of morbidity and mortality in patients with malignancy. In patients with cancer compared with those without, the risk of developing vte is increased by a factor in the range of 4-71. Compared with patients having cancer . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.